✦ LIBER ✦

Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: A Phase I dose escalating study in healthy volunteers

✍ Scribed by Heldens, Jacco; Hulskotte, Ellen; Voeten, Theo; Breedveld, Belinda; Verweij, Pierre; van Duijnhoven, Wilbert; Rudenko, Larissa; van Damme, Pierre; van den Bosch, Han

Book ID: 124113731
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 354 KB
Volume: 32
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2014.05.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a trivalent

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

✍ Scott A Halperin; Bruce Smith; Taoufik Mabrouk; Marc Germain; Pierre Trépanier; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Safety and immunogenicity of a plant-pro

Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-escalation study in healthy adults

✍ Cummings, James F.; Guerrero, Melanie L.; Moon, James E.; Waterman, Paige; Niels 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 858 KB

Safety and immunogenicity of a trivalent

Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: A phase III open-label single-arm study

✍ M. Loebermann; G. Anders; G. Brestrich; C. Fritzsche; S. Klammt; D. Boršo; S. Fr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 267 KB

A randomised, single-blind, dose-range s

A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations

✍ Christoph Hatz; Jakob P. Cramer; André Vertruyen; Tino F. Schwarz; Frank von Son 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 376 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants

✍ David I. Bernstein; Judith Falloon; Tingting Yi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 596 KB